NSE · 3BBLACKBIO

3B Blackbio Dx Limited

Sector: Healthcare · ISIN: INE994E01018

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#1,438

of 5,072 stocks

▲ 591W

Peak #1,438 · 27 Sep 2026

3B Blackbio Dx Limited, a smallcap Healthcare business, is growing revenue rapidly, trades at a moderate earnings multiple, and earns a healthy return on equity. Ownership as of Jun 2026.

Market Cap

1,247.73 Cr

P/E Ratio

20.82

P/B Ratio

3.76

ROE

18.07%

ROCE

22.61%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	33.49 Cr	35.43 Cr	50.35 Cr	33.90 Cr
Net Profit	8.98 Cr	9.80 Cr	22.44 Cr	15.04 Cr
EPS	10.48	11.44	26.19	17.55
Operating Profit	13.32 Cr	14.75 Cr	26.93 Cr	19.66 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

40.95%

Public

59.05%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

₹0.03

Cr total

Schemes

Fund Houses

₹0.03 Cr

Total Exposure

Motilal Oswal Mutual Fund₹0.02 Cr (65.1%)

Bandhan Mutual Fund₹0.01 Cr (34.9%)

Scheme	Fund House	Value (Cr)	%

All MF holders by market value as of 01 Jul 2026.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs